There are no Focus articles on AZNDF.
There are no Related articles on AZNDF.
There are no Transcripts on AZNDF.
There are no News articles on AZNDF.
Tue, Aug. 19, 4:45 AM
- AstraZeneca (NYSE:AZN) says that the U.S. government has closed a probe that investigated a major clinical trial used to win marketing approval for the company's new heart drug Brilinta.
- Following the DOJ's investigation into the study last October, doubts have ensued over the medicine's future success.
- AstraZeneca argues that Brilinta can bring in $3.5B in annual sales, although until now the drug has not made any record performance.
There are no StockTalks on this stock yet.
AZNDF vs. ETF Alternatives
Other News & PR